Filed Pursuant to Rule 433
Registration Statement No. 333-210531
Dated August 7, 2017
CNA Financial Corporation
$500,000,000
3.450% Notes Due 2027
|
Issuer: |
|
CNA Financial Corporation |
|
|
|
|
|
Format: |
|
SEC Registered |
|
|
|
|
|
Securities: |
|
3.450% Notes due 2027 |
|
|
|
|
|
Security Type: |
|
Senior Unsecured Fixed Rate Notes |
|
|
|
|
|
Trade Date: |
|
August 7, 2017 |
|
|
|
|
|
Settlement Date: |
|
August 10, 2017 (T + 3) |
|
|
|
|
|
Maturity Date: |
|
August 15, 2027 |
|
|
|
|
|
Interest Payment Dates: |
|
Semi-annually on August 15 and February 15, commencing on February 15, 2018 |
|
|
|
|
|
Principal Amount: |
|
$500,000,000 |
|
|
|
|
|
Treasury Benchmark: |
|
UST 2.375% due May 15, 2027 |
|
|
|
|
|
Treasury Benchmark Yield: |
|
2.257% |
|
|
|
|
|
Spread to Treasury Benchmark: |
|
T + 122 basis points |
|
|
|
|
|
Yield to Maturity: |
|
3.477% |
|
|
|
|
|
Coupon: |
|
3.450% |
|
|
|
|
|
Price to Public: |
|
99.773% of principal amount |
|
|
|
|
|
Net Proceeds, before expenses: |
|
$495,615,000 |
|
|
|
|
|
Optional Redemption: |
|
At any time prior to May 15, 2027 at a discount rate of US Treasury + 20 basis points or on or after May 15, 2027 at par |
|
|
|
|
|
CUSIP / ISIN: |
|
126117AU4 / US126117AU49 |
|
|
|
|
|
Joint Book-Running Managers: |
|
Barclays Capital Inc. Merrill Lynch, Pierce, Fenner & Smith U.S. Bancorp Investments, Inc. |
|
|
|
|
|
Co-Manager: |
|
Samuel A. Ramirez & Company, Inc. |
The issuer has filed a registration statement, including a prospectus, with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the Joint Book-Running Managers in the offering will arrange to send you the prospectus if you request it toll free by calling Barclays Capital Inc. at (888) 603-5847 or Wells Fargo Securities, LLC at (800) 645-3751.